Smith & Nephew (LON:SN) Stock Passes Above 200 Day Moving Average – What’s Next?

Smith & Nephew plc (LON:SN)’s stock price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 1,175.86 ($15.66) and traded as high as GBX 1,328.50 ($17.70). Smith & Nephew shares last traded at GBX 1,324 ($17.64), with a volume of 2,986,359 shares traded.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on the company. JPMorgan Chase & Co. raised their target price on Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the stock an “overweight” rating in a research report on Wednesday, August 6th. Deutsche Bank Aktiengesellschaft raised their target price on Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the stock a “hold” rating in a research report on Wednesday, August 6th. Finally, Berenberg Bank raised their target price on Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the stock a “hold” rating in a research report on Thursday, August 7th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of GBX 1,379.33.

Smith & Nephew Stock Performance

The company has a 50-day moving average price of GBX 1,364.40 and a two-hundred day moving average price of GBX 1,175.86. The company has a current ratio of 2.51, a quick ratio of 0.84 and a debt-to-equity ratio of 70.22. The stock has a market capitalization of £14.37 billion, a P/E ratio of 47.20, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62.

Insider Transactions at Smith & Nephew

In other Smith & Nephew news, insider Jo Hallas acquired 389 shares of the stock in a transaction dated Friday, August 22nd. The stock was purchased at an average cost of GBX 1,384 per share, with a total value of £5,383.76. Also, insider Katarzyna Mazur Hofsaess acquired 541 shares of the stock in a transaction dated Friday, August 22nd. The stock was acquired at an average cost of GBX 1,385 per share, with a total value of £7,492.85. In the last 90 days, insiders purchased 4,811 shares of company stock worth $12,947,701. Corporate insiders own 0.19% of the company’s stock.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.